Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve In terms of Regulation ....
SUPRIYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Supriya Lifescience Ltd has announced a Board meeting scheduled for May 27, 2026. The meeting will consider and approve the Audited Financial Results for Q4 and the financial year ended March 31, 2026. Additionally, the board will recommend dividend, if any, on the company's equity shares for FY2026. The company has also confirmed that the Trading Window remains closed for Designated Persons and their immediate relatives from April 1, 2026 until 48 hours after the results declaration. This is a routine regulatory intimation under SEBI LODR Regulation 29.
This announcement signals upcoming quarterly/annual results and potential dividend declaration, which could impact investor sentiment. The closed trading window indicates no insider trading concerns. Shareholders should watch for the results announcement on or after May 27, 2026.